Cargando...
Why aren’t we doing better in asthma: time for personalised medicine?
After decades of improvement, asthma outcomes have stalled. Mortality, hospitalisations, exacerbations and symptom control remain sub-optimal. In controlled trials, most patients gain high levels of control, but in ‘real-life’ routine clinical practice most patients do not. Avoidable factors are fou...
Gardado en:
| Publicado en: | NPJ Prim Care Respir Med |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Nature Publishing Group
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4373498/ https://ncbi.nlm.nih.gov/pubmed/25741858 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npjpcrm.2015.4 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|